About Opus Genetics
Opus Genetics is a private company based in Durham, North Carolina, incorporated in 2021 in Delaware. It has reported $14,001,973 raised in two offerings on Form D since August 2021. Its chief executive is Benjamin Yerxa.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 5, 2023 | Jun 27, 2023 | $4,501,972of $20.0M target | 5 | $900K | Equity, Debt, OptionsRule 506(b) | Form D ↗ |
| Aug 5, 2021 | Aug 20, 2021 | $9,500,001of $19.0M target | 5 | $1.9M | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $14,001,973 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Opus Genetics's Form D filed Jun 27, 2023.